Creation of a Means of Providing the UK with Future Pandemic Preparedness

Creation of a Means of Providing the UK with Future Pandemic Preparedness

The VTF seeks to better understand, and explore the possibilities for, plant-derived vaccines from potential suppliers who are experienced in pharmaceutical production.

United Kingdom-London: Vaccines

2020/S 224-551964

Prior information notice

This notice is for prior information only

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: The Department for Business, Energy and Industrial Strategy (BEIS)
Postal address: 1 Victoria Street
Town: London
NUTS code: UKI LONDON
Postal code: SW1H 0ET
Country: United Kingdom
E-mail: VTFContracts@beis.gov.uk
Telephone: +44 2072152967
Internet address(es):
Main address: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy

I.2)Information about joint procurement

The contract is awarded by a central purchasing body

I.3)Communication

Additional information can be obtained from the abovementioned address

I.4)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5)Main activity

General public services

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Creation of a Means of Providing the UK with Future Pandemic Preparedness — Call for Expressions of Interest

 

Reference number: 2020/NOV/LAR/001

II.1.2)Main CPV code

33651600 Vaccines

II.1.3)Type of contract

Supplies

II.1.4)Short description:

The VTF seeks to better understand, and explore the possibilities for, plant-derived vaccines from potential suppliers who are experienced in pharmaceutical production. We are looking to establish a UK-based manufacturing capability to produce these vaccines and are willing to invest to bring this about. Should we proceed to procurement, it will be for the purchase of vaccines, derived from plants, produced in UK-based facilities. One of the objectives of this exercise is to inform the procurement strategy including establishing the extent of funding required.

 

II.1.5)Estimated total value

Value excluding VAT: 1.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM
Main site or place of performance:

UNITED KINGDOM.

 

II.2.4)Description of the procurement:

The VTF seeks to better understand, and explore the possibilities for, plant-derived vaccines from potential suppliers who are experienced in pharmaceutical production or who have other relevant expertise and/or insight. We are looking to establish a UK-based manufacturing capability to produce these vaccines and are willing to invest to bring this about. Should we proceed to procurement, it will be for the purchase of vaccines, derived from plants, produced in UK-based facilities.

 

II.2.14)Additional information

Expressions of interest are requested from the market by 21 November on 22 November, a document, which includes a questionnaire, to inform our procurement approach, will be sent to interested parties. This will then need to be completed and returned by 11 December.

 

II.3)Estimated date of publication of contract notice:

21/12/2020

Section IV: Procedure

IV.1)Description

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes

Section VI: Complementary information

VI.3)Additional information:

 

Project objectives

• establish if a supplier market exists for the supply of plant-derived vaccines;

• develop a UK vaccine production base, which does not exist today, capable of switching between Covid-19 and flu vaccine production;

• achieve best value for money;

• achieve a share of risk.

To view this notice, please click here:

https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=535934269

GO Reference: GO-20201112-PRO-17359305

 

VI.5)Date of dispatch of this notice:

12/11/2020